Abstract
Introduction
Acetyl-l-carnitine (Nicetile® fiale; Biofutura Pharma S.p.A., Sigma Tau group, Milano, Italy) is a compound widely used for the treatment of many diseases, such as neuropathies, diabetic polyneuropathy, and Parkinson’s disease. It is frequently administered via the intramuscular route with other drugs, such as steroidal anti.inflammatories, muscle relaxants, and vitamins.
Methods
In the present study the behavior of acetyl-l-carnitine injections (Nicetile® fiale) with different drugs used for combined therapy was studied. Physicochemical properties including color, clarity, pH, and drug content were observed before and after mixing at room temperature.
Results
The content of all the active drugs after mixing remained optimal within 10% of their nominal values.
Conclusions
The measurements demonstrate the physicochemical compatibility between Nicetile fiale and the other tested products, meaning that there is no evidence of interactions and degradation.
Similar content being viewed by others
References
Beal MF. Bioenergetic approaches for neuroprotection in Parkinson’s disease. Ann Neurol. 2003;53(suppl. 3):S39–S48.
Ashworth N. Carpal tunnel syndrome. Am Fam Physician. 2007;75:381–383.
Alfonso C, Jann S, Massa R, Torreggiani A. Diagnosis, treatment and follow-up of the carpal tunnel syndrome. Neurol Sci. 2010;31:1–10.
De Grandis D. Tolerability and efficacy of l-acetyl-carnitine in the treatment of patients with peripheral neuropaties. A short term, open multicenter study. Clin Drug Invest. 1998;16:73–79.
Schenone A. Diagnosi, classificazione e principi di terapia delle neuropatie periferiche. Ital J Neurol Sci. 2007;2:12–20.
Willison JH, Winer JB. Clinical evaluation and investigation of neuropathy. J Neurol Neurosurg Psychiatr. 2003;74(suppl. II):ii3–ii8.
Hart AM, Wiberg M, Terenghi G. Pharmacological enhancement of peripheral nerve regeneration in the rat by systemic acetyl-l-carnitine treatment. Neurosci Lett. 2002;334:181–185.
Blum K, Seifter E, Seifter J. The pharmacology of d- and l- carnitine and d- and l-acetylcarnitine: comparison with choline and acetylcholine. J Pharmacol Exp Ther. 1971;178:331–338.
Scarpini E, Doneda P, Pizzul S, et al. l-Carnitine and acetyl-l-carnitine in human nerves from normal and diabetic subjects. J Peripher Nerv Syst. 1996;1:157–163.
Ido Y, McHowan J, Chang KC, et al. Neural dysfunction and metabolic imbalances in diabetics rats: prevention by acetyl-l-carnitine. Diabetes. 1994;43:1469–1477.
Sima AA, Calvani M, Mehra M, Amato A, Acetyl-l-carnitine Study Group. Acetyl-l-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy, an analysis of two randomized placebo-controlled trials. Diabetes Care. 2005;28:89–94.
Hathcock JN, Shao A. Risk assessment for carnitine. Regul Toxicol Pharmacol. 2006;4:23–28.
Anacardio R, Perilli O, Pagnanelli F, et al. Physicochemical compatibility between thiocolchicoside injections (Miotens®) and pharmaceutical products frequently used for combined therapy. Farmaco. 2002;57:925–930.
Yalkowsky SH. Formulation-related problems associated with intravenous drug delivery. J Pharm Sci. 1998;87:787–796.
Pifferi G. Compatibilità chimico-fisica tra tiocolchicoside e farmaci antinfiammatori non steroidei. Boll Chim Farm. 1993;132:203–209.
Carlucci G, Gentile MM, Bartolini S, Anacardio R. Physicochemical compatibility between ketoprofen lysine salt injections (Oki® fiale PG060) and pharmaceutical products frequently used for combined therapy. Boll Chim Farm. 2004;1:15–19.
Anacardio R, Perilli O, Pagnanelli F, et al. Physicochemical compatibility between ketoprofen lysine salt injections (Artrosilene®) and pharmaceutical products frequently used for combined therapy by intravenous administration. J Pharm Biomed Anal. 2003;32:1235–1241.
Amidžić R, Brboric J, Čudina O, Vladimirov S. RPHPLC determination of vitamins B1, B3, B6, folic acid and B12 in multivitamin tablets. J Serb Chem Soc. 2005;70:1229–1235.
Aslam J, Mohajir MS, Khan SA, Khan AQ. HPLC analysis of water-soluble vitamins (B1, B2, B3, B5, B6) in in vitro and ex vitro germinated chickpea (Cicer arietinum L.). Afr J Biotechnol. 2008;7:2310–2314.
Thomas S, Kumar R, Sharma A, Issarani R, Nagori BP. Stability-indicating HPLC method for determination of vitamins B1, B2, B3 and B6 in pharmaceutical liquid dosage form. Ind J Chem Technol. 2008;15:598–603.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Sinicropi, M.S., Leone, F., Rovito, N. et al. Behavior of acetyl-l-carnitine injections (Nicetile® fiale) with different drugs used for combined therapy. Adv Therapy 27, 547–554 (2010). https://doi.org/10.1007/s12325-010-0055-0
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12325-010-0055-0